BIOGEN INC. Employee-related Liabilities
BIOGEN INC. (BIIB) had Employee-related Liabilities of $178.10 million as of 2014-09-30, per its 10-Q filed 2014-10-22.
Discontinued › Balance Sheet › Liabilities
us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent · last filed 2014-10-22
- 2014-09-30: Employee-related Liabilities $178.10M.
- 2014-03-31: Employee-related Liabilities $198.10M.
- 2013-12-31: Employee-related Liabilities $343.40M.
- 2013-09-30: Employee-related Liabilities $261.50M.
| Period end | Employee-related Liabilities |
|---|---|
| 2014-09-30 | $178.10M 10-Q · filed 2014-10-22 |
| 2014-03-31 | $198.10M 10-Q · filed 2014-04-23 |
| 2013-12-31 | $343.40M 10-Q · filed 2014-04-23 |
| 2013-09-30 | $261.50M 10-Q · filed 2013-10-28 |
| 2013-06-30 | $213.30M 10-Q · filed 2013-07-25 |
| 2012-12-31 | $248.50M 10-Q · filed 2013-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |